[{"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention1: SARS-CoV-2 (COVID-19) AntiserumImmunoglobulins (Purified F(ab)2 fragment along with standard ofcare: Patients in this group will receive two 4mLdoses (at day 0 and Day 1) of BioE\u00e2??s SARS-CoV-2 (COVID-19) Antiserum Immunoglobulins(Purified F(ab)2 fragment) intravenously along with standard of care.Control Intervention1: Standard care for Covid-19 patients: Patients in this group will receive only standard of care for Covid-19patients.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention1: SARS-CoV-2 (COVID-19) AntiserumImmunoglobulins (Purified F(ab)2 fragment along with standard ofcare: Patients in this group will receive two 4mLdoses (at day 0 and Day 1) of BioE\u00e2??s SARS-CoV-2 (COVID-19) Antiserum Immunoglobulins(Purified F(ab)2 fragment) intravenously along with standard of care.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Control Intervention1: Standard care for Covid-19 patients: Patients in this group will receive only standard of care for Covid-19patients.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "", "treatment_id": 1152, "treatment_name": "Sars-cov-2 equine antiserum immunoglobulin (purified f(ab)2 fragment)", "treatment_type": "Immunoglobulins sars-cov-2 specific", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]

[{"arm_notes": "", "treatment_id": null, "treatment_name": "N/A", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention1: SARS-CoV-2 (COVID-19) AntiserumImmunoglobulins (Purified F(ab)2 fragment along with standard ofcare: Patients in this group will receive two 4mLdoses (at day 0 and Day 1) of BioE\u00e2??s SARS-CoV-2 (COVID-19) Antiserum Immunoglobulins(Purified F(ab)2 fragment) intravenously along with standard of care.Control Intervention1: Standard care for Covid-19 patients: Patients in this group will receive only standard of care for Covid-19patients.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention1: SARS-CoV-2 (COVID-19) AntiserumImmunoglobulins (Purified F(ab)2 fragment along with standard ofcare: Patients in this group will receive two 4mLdoses (at day 0 and Day 1) of BioE\u00e2??s SARS-CoV-2 (COVID-19) Antiserum Immunoglobulins(Purified F(ab)2 fragment) intravenously along with standard of care.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Control Intervention1: Standard care for Covid-19 patients: Patients in this group will receive only standard of care for Covid-19patients.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]